Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

Paul Goode, President & CEO, GlucoTrack, was recently a guest on Benzinga's All-Access. GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company's vision is to create a future where diabetes management is automatic and inconspicuous, empowering people to live boldly and unapologetically.